RBC Capital analyst Frank Morgan maintains Cigna (NYSE:CI) with a Outperform and raises the price target from $265 to $304.
Uncategorized
RBC Capital Maintains Outperform on Cigna, Raises Price Target to $304
RBC Capital analyst Frank Morgan maintains Cigna (NYSE:CI) with a Outperform and raises the price target from $265 to $304.
Related Posts
Polyrizon Submites Patent Application For Its Platform Technologies
Tel Aviv, Israel, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle ("EV") and
SI-BONE: Q3 Earnings Insights
SI-BONE (NASDAQ:SIBN) reported its Q3 earnings results on Monday, November 8, 2021 at 04:00 PM.
Here's what investors need to know about the announcement.
William Blair Initiates Coverage On Rover Group with Outperform Rating
William Blair analyst Ralph Schackart initiates coverage on Rover Group (NASDAQ:ROVR) with a Outperform rating.